Status:
NOT_YET_RECRUITING
Norepinephrine and Phenylephrine for Spinal Anesthesia-induced Hypotension.
Lead Sponsor:
General Hospital of Ningxia Medical University
Conditions:
Outcome
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This study aims to explore the effects of different application modes (prophylactic and rescue strategy) of norepinephrine and norepinephrine on neonate umbilical artery pH undergoing cesarean section...
Detailed Description
Spinal anesthesia-induced hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of spinal anesthesia-induced hypotension is as high as 62.1-89.7% if proph...
Eligibility Criteria
Inclusion
- 18-45 years
- Primipara or multipara
- Singleton pregnancy ≥37 weeks
- American Society of Anesthesiologists physical status classification II
- Scheduled for cesarean section under spinal anesthesia
Exclusion
- Body height \< 150 cm
- Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2
- Eclampsia or chronic hypertension or baseline blood pressure ≥140 mmHg
- Hemoglobin \< 7g/dl
- Fetal distress, or known fetal developmental anomaly
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06508359
Start Date
March 1 2025
End Date
February 28 2027
Last Update
July 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.